A multi-target directed ligands strategy for the treatment of Alzheimer’s disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator

Publication date: 15 November 2022Source: European Journal of Medicinal Chemistry, Volume 242Author(s): Jie Guo, Maojun Cheng, Peng Liu, Duanyuan Cao, Jinchong Luo, Yang Wan, Yuanying Fang, Yi Jin, Sai-Sai Xie, Jing Liu

Design, synthesis and biological evaluation of (Quinazoline 4-yloxy)acetamide and (4-oxoquinazoline-3(4<em>H</em>)-yl)acetamide derivatives as inhibitors of <em>Mycobacterium tuberculosis bd</em> oxidase

Publication date: 15 November 2022Source: European Journal of Medicinal Chemistry, Volume 242Author(s): Amit Kumar, Neetu Kumari, Sandeep Bhattacherjee, Umamageswaran Venugopal, Shahid Parwez, Mohammad Imran Siddiqi, Manju Y. Krishnan, Gautam Panda

Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancers

Publication date: 15 November 2022Source: European Journal of Medicinal Chemistry, Volume 242Author(s): Francisco Martínez-Peña, Aaron D. Pearson, Eileen L. Tang, Nick A. Kuburich, Sendurai A. Mani, Peter G. Schultz, Michael J. Bollong, Luke L. Lairson

Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases

Publication date: 15 November 2022Source: European Journal of Medicinal Chemistry, Volume 242Author(s): Haobai Liu, Quan Wang, Yue Huang, Jinhui Deng, Xi Xie, Jiaqi Zhu, Yijun Yuan, Yue-Ming He, Yi-You Huang, Hai-Bin Luo, Xixin He